New Article: Ben Arye et al, Perspectives of Arab Patients in Palestine and Israel on the Role of Complementary Medicine

Ben-Arye, Eran, Amneh M.A. Hamadeh, Elad Schiff, Rana M. Jamous, Jamal Dagash, Rania M. Jamous, Abed Agbarya, Gil Bar-Sela, Eyas Massalha, Michael Silbermann, and Mohammed Saleem Ali-Shtayeh. “Compared Perspectives of Arab Patients in Palestine and Israel on the Role of Complementary Medicine in Cancer Care.” Journal of Pain and Symptom Management 49.5 (2015): 878-84.

 

URL: http://dx.doi.org/10.1016/j.jpainsymman.2014.10.006

 

Abstract

Context

Complementary medicine (CM) is extensively used by patients with cancer across the Middle East.

Objectives

We aimed to compare the perspectives of two Arab populations residing in diverse socioeconomic-cultural settings in Palestine and Israel regarding the role of CM in supportive cancer care.

Methods

A 27-item questionnaire was constructed and administered to a convenience sample of Arab patients receiving cancer care in four oncology centers in northern Israel and Palestine.

Results

Each of the two groups had 324 respondents and was equally distributed by age and marital status. Compared with the Israeli-Arab group, Palestinian participants reported significantly higher CM use for cancer-related outcomes (63.5% vs. 39.6%, P < 0.001), which included more herbal use (97.6% vs. 87.9%, P = 0.001) and significantly lower use of dietary supplements, acupuncture, mind-body and manual therapies, and homeopathy. Most respondents in both groups stated that they would consult CM providers if CM was integrated in oncology departments. Related to this theoretical integrative scenario, Palestinian respondents expressed fewer expectations from their oncologists to actively participate in building their CM treatment plan. Treatment expectations in both groups focused on improving quality of life (QOL), whereas Palestinian respondents had fewer expectations for CM to improve fatigue, emotional concerns, sleep, and daily functioning.

Conclusion

Arab patients with cancer from Palestine and Israel highly support CM integration within their oncology institutions aiming to improve QOL. Nevertheless, respondents differed in their perceived model of CM integration, its treatment objectives, and their oncologists’ role in CM integration.